Fig. 3: Advantages of implementing MNMS for key stakeholders.
From: A minimal metadata set (MNMS) to repurpose nonclinical in vivo data for biomedical research
This figure illustrates the multifaceted benefits of MNMS across different stakeholders. For researchers, MNMS facilitates the creation of highly regulated and homogeneous experimental conditions, enhancing experiment repeatability, reducing resource use and addressing ethical considerations. Regulatory organizations and funding agencies benefit through the support of greater transparency, accountability and animal welfare, with MNMS enabling standardized experiments and reduced research costs. From the perspective of (bio)statisticians, MNMS increases the precision and replicability of statistical analyses by eliminating confounding variables, harmonizing data collection and ensuring a more regulated research environment. This comprehensive representation underscores MNMS’s role in advancing responsible, efficient and high-quality research practices.
